CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 34 enrolled
Drug / intervention
2007-2008 Influenza Virus Vaccine +1 morebiological
Likely dose
2007-2008 Influenza Virus Vaccine 0.25 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00561002
NCT00561002Phase 4Completed
CompareCT.gov

Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2007-2008 Formulation)

Sanofi Pasteur, a Sanofi Company·interventional·Posted Nov 20, 2007·Updated Apr 14, 2016

In Brief

A Phase 4 clinical trial evaluating 2007-2008 Influenza Virus Vaccine for Influenza. Completed, enrolled 34 participants across 1 site.

Detailed Summary

To provide Centers for Biologic Evaluation and Research (CBER) with sera collected from healthy children receiving the 2007-2008 formulation of the inactivated, split-virion influenza vaccine Fluzone® for further study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 20, 2007
Enrollment StartOct 1, 2007
Primary CompletionMay 1, 2008
Study CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 18.6 years ago

Interventions

2007-2008 Influenza Virus Vaccinebiological

0.25 mL, Intramuscular

2007-2008 Influenza Virus Vaccinebiological

0.25 mL, Intramuscular